tolcapone [Ligand Id: 6646] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1324 (RO 40-7592, RO-40-7592, RO-407592, Tasmar, Tolcapona, Tolcapone)
There should be some charts here, you may need to enable JavaScript!
  • Catechol-O-methyltransferase/Catechol O-methyltransferase in Human [ChEMBL: CHEMBL2023] [GtoPdb: 2472] [UniProtKB: P21964]
  • Catechol-O-methyltransferase/Catechol O-methyltransferase in Rat [ChEMBL: CHEMBL2372] [GtoPdb: 2472] [UniProtKB: P22734]
There should be some charts here, you may need to enable JavaScript!
  • Dengue virus type 2 NS3 protein in Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) [ChEMBL: CHEMBL5980] [UniProtKB: P29990]
There should be some charts here, you may need to enable JavaScript!
  • Genome polyprotein in West Nile virus [ChEMBL: CHEMBL5419] [UniProtKB: P06935]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
ABCB11/Bile salt export pump in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073674] [GtoPdb: 778] [UniProtKB: O70127]
ChEMBL Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake B 4.33 pIC50 47200 nM IC50 Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623]
Catechol-O-methyltransferase/Catechol O-methyltransferase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2023] [GtoPdb: 2472] [UniProtKB: P21964]
GtoPdb membrane-bound enzyme - 9.54 pKi 0.29 nM Ki Biochemistry (1995) 34: 4202-10 [PMID:7703232]
GtoPdb soluble enzyme - 9.57 pKi 0.27 nM Ki Biochemistry (1995) 34: 4202-10 [PMID:7703232]
ChEMBL Inhibition of human recombinant His-tagged soluble COMT expressed in Escherichia coli BL21 using aesculetin as substrate after 60 mins by microplate assay in presence of SAM B 6.9 pIC50 127 nM IC50 J Med Chem (2016) 59: 4664-4675 [PMID:27074629]
ChEMBL Inhibition of c-terminal hexa-His tagged human MB-COMT (unknown origin) B 9 pIC50 <1 nM IC50 J Med Chem (2018) 61: 9647-9665 [PMID:30272964]
ChEMBL Inhibition of human MB-COMT expressed in HEK293 cells using dopamine as substrate and SAM as cofactor preincubated for 30 mins followed by substrate addition and measured after 40 mins by HTRF assay B 9 pIC50 <1 nM IC50 ACS Med Chem Lett (2019) 10: 1573-1578 [PMID:32038769]
Catechol-O-methyltransferase/Catechol O-methyltransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2372] [GtoPdb: 2472] [UniProtKB: P22734]
ChEMBL Inhibitory activity against COMT in rat brain B 5.66 pIC50 2200 nM IC50 J Med Chem (2005) 48: 8070-8078 [PMID:16335931]
ChEMBL Inhibitory activity against COMT in rat liver B 6.03 pIC50 930 nM IC50 J Med Chem (2005) 48: 8070-8078 [PMID:16335931]
ChEMBL Inhibition of S-COMT in rat liver homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins B 7.28 pIC50 53 nM IC50 Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233]
ChEMBL Inhibition of S-COMT in Wistar rat liver assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 5 mins by chromatographic analysis B 7.51 pIC50 30.59 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
ChEMBL Inhibition of MB-COMT in rat liver homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins B 7.77 pIC50 17 nM IC50 Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233]
ChEMBL Inhibition of MB-COMT in rat brain homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins B 8.52 pIC50 3 nM IC50 Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233]
ChEMBL Inhibition of rat COMT B 8.66 pIC50 2.2 nM IC50 Bioorg Med Chem (2016) 24: 1419-1430 [PMID:26935940]
ChEMBL Inhibition of Catechol O-methyltransferase activity in rat brain B 8.66 pIC50 2.2 nM IC50 J Med Chem (2002) 45: 685-695 [PMID:11806720]
ChEMBL Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis B 9.04 pIC50 0.91 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
ChEMBL Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis B 9.04 pIC50 0.91 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
Dengue virus type 2 NS3 protein in Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5980] [UniProtKB: P29990]
ChEMBL Inhibition of DENV2 NS2B-NS3 serine protease expressed using Benzoyl-Nle-Lys-Arg-Arg-AMC as substrate measured preincubated for 3 mins followed by substrate addition by fluorescence assay B 6.19 pIC50 640 nM IC50 Eur J Med Chem (2019) 176: 431-455 [PMID:31128447]
ChEMBL Inhibition of Dengue Virus 1 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins B 6.19 pIC50 640 nM IC50 Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454]
ChEMBL Inhibition of Dengue Virus 2 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins B 6.19 pIC50 640 nM IC50 Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454]
ChEMBL Inhibition of Dengue Virus 3 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins B 6.19 pIC50 640 nM IC50 Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454]
ChEMBL Inhibition of Dengue Virus 4 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins B 6.19 pIC50 640 nM IC50 Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454]
ChEMBL Inhibition of NS2B-NS3 protease in DENV2proHeLa system assessed as inhibition of luciferase signal incubated for 24 hrs by luciferase reporter gene assay B 5.15 pEC50 7100 nM EC50 J Med Chem (2021) 64: 4567-4587 [PMID:33851839]
Genome polyprotein in West Nile virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5419] [UniProtKB: P06935]
ChEMBL Inhibition of West Nile virus NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Lys-Arg-Arg-AMC as substrate assessed as proteolytic activity by monochrometer-based spectrofluorometeric analysis B 6.15 pIC50 700 nM IC50 RSC Med Chem (2021) 12: 1262-1272 [PMID:34458734]
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97]
ChEMBL Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay B 4.31 pEC50 49200 nM EC50 Medchemcomm (2012) 3: 1270-1274
ChEMBL Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis B 5.13 pEC50 7440 nM EC50 Medchemcomm (2012) 3: 1270-1274
Krueppel-like factor 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3407312] [UniProtKB: Q13118]
ChEMBL Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in transcriptional activity after 24 hrs by CACCC-responsive promoter driven TK-luciferase reporter gene assay B 4.3 pIC50 50000 nM IC50 J Med Chem (2015) 58: 1466-1478 [PMID:25581017]
ChEMBL Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in KLF10-mediated transcriptional activity incubated for 24 hrs by luciferase reporter assay B 4.3 pIC50 50000 nM IC50 US-20170121318-A1. Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy (2017)
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766]
ChEMBL Binding affinity to TTR V30M mutant (unknown origin) expressed in Escherichia coli incubated for 60 mins by tryptophan intrinsic fluorescence method B 6.01 pKd 980 nM Kd J Med Chem (2021) 64: 14344-14357 [PMID:34547896]
ChEMBL Binding affinity to TTR V30M mutant (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis B 6.36 pKd 440 nM Kd Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673]
ChEMBL Binding affinity to TTR V30M mutant (unknown origin) by isothermal titration calorimetry B 7.02 pKd 95 nM Kd J Med Chem (2021) 64: 14344-14357 [PMID:34547896]
ChEMBL Binding affinity to transthyretin V122I mutant (unknown origin) by ITC method B 7.25 pKd 56 nM Kd J Med Chem (2018) 61: 7862-7876 [PMID:30133284]
ChEMBL Binding affinity to TTR V122I mutant (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis B 7.3 pKd 50 nM Kd Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673]
ChEMBL Binding affinity to wild-type TTR (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis B 7.32 pKd 48 nM Kd Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673]
ChEMBL Binding affinity to wild type TTR (unknown origin) assessed as dissociation constant by ITC assay B 7.47 pKd 34 nM Kd J Med Chem (2022) 65: 14673-14691 [PMID:36306808]
ChEMBL Binding affinity to wild type TTR (unknown origin) assessed as gibbs free energy change by ITC analysis B 7.47 pKd 34 nM Kd J Med Chem (2022) 65: 14673-14691 [PMID:36306808]
ChEMBL Binding affinity to transthyretin (unknown origin) by ITC method B 7.69 pKd 20.6 nM Kd J Med Chem (2018) 61: 7862-7876 [PMID:30133284]
ChEMBL Stabilization of wild type TTR (unknown origin) expressed in Escherichia coli assessed as reduction in methanol-induced aggregation incubated for 60 min by absorbance method B 4.52 pIC50 30000 nM IC50 J Med Chem (2021) 64: 14344-14357 [PMID:34547896]
ChEMBL Stabilization of TTR V30M mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio incubated for 1 week by absorbance method B 5.49 pIC50 3200 nM IC50 J Med Chem (2021) 64: 14344-14357 [PMID:34547896]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]